Erratum to "CSF proteomic fingerprints for HIV-associated cognitive impairment". [J. Neuroimmunol. 192(2007)157-170] (DOI:10.1016/j.jneuroim.2007.08.004);CSF proteomic fingerprints for HIV-associated cognitive impairment

Journal of Neuroimmunology

Volumn 192, Issue 1-2, 2007, Pages 157-170

  Laspiur, Juliana Pérez ^a   Anderson, Eric R ^a   Ciborowski, Pawel ^d   Wojna, Valerie ^a,b   Rozek, Wojciech ^d,e   Duan, Fenghai ^c   Mayo, Raul ^a,b   Rodríguez, Elaine ^a   Plaud Valentín, Marinés ^a   Rodríguez Orengo, José ^b   Gendelman, Howard E ^d   Meléndez, Loyda M ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

Author keywords

Biomarkers; CSF; HIV associated cognitive impairment; Proteomics

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FINGER DERMATOGLYPHICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 36749096223     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.07.009     Document Type: Erratum

References (49)

1. Ahmad K. HIV may underlie ALS-like condition. Lancet, Infect. Dis. 1 (2001) 217
2. American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS task force. Neurology 41 (1991) 778-785
3. American Academy of Neurology AIDS Task Force. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 47 (1996) 1247-1253
4. Ances B.M., and Ellis R.J. Dementia and neurocognitive disorders due to HIV-1 infection. Semin. Neurol. 27 (2007) 86-92
5. Anthony I.C., Ramage S.N., Carnie F.W., Simmonds P., and Bell J.E. Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 64 (2005) 529-536
6. Berger J.R., Avison M., Mootoor Y., and Beach C. Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations. J. Neurovirology 11 (2005) 557-562
7. Beyer S., Walter Y., Hellmann J., Kramer P.J., Kopp-Schneider A., Kroeger M., and Ittrich C. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra. J. Proteome Res. 5 2 (2006) 254-261
8. Boven L.A., Gomes L., Hery C., Gray F., Verhoef J., Portegies P., Tardieu M., and Nottet H.S.L.M. Increased peroxynitrite activity in AIDS dementia complex: implications for the neurogenesis of HIV-infection. J. Immunol. 162 (1999) 4319-4327
9. Carrette O., Burgess J.A., Burkhard P.R., Lang C., Cote M., Rodrigo N., Hochstrasser D.F., and Sanchez J.C. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 3 (2003) 1486-1494
10. Ciborowski P., Kadiu I., Rozek W., Smith L., Bernhardt P., Fladseth M., Ricardo-Dukelow M., and Gendelman H.E. Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 363 (2007) 198-209
11. Cone L.A., Nazemi R., and Cone M.O. Reversible ALS-like disorder in HIV infection. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 59 (2001) 474-475
12. Enose Y., Destache C.J., Mack A.L., Anderson J.R., Ullrich F., Ciborowski P.S., and Gendelman H.E. Proteomic fingerprints distinguish microglia, bone marrow, and spleen macrophage populations. Glia 51 (2005) 161-172
13. Everall I.P., Hansen L.A., and Masliah E. The shifting patterns of HIV encephalitis neuropathology. Neurotox. Res. 8 (2005) 51-61
14. Gelman B., Soukup V.M., Holzer C.E., Fabian R.H., Schuenke K.W., Keherly M.J., Richey F.J.R.N., and Lahart C.J. Potential role for white matter lysosome expansion in HIV-associated dementia. J. AIDS/HIV 39 (2005) 422-425
15. Glanzer J.G., Enose Y., Wang T., Kadiu L., Gong N., Rozek W., Liu J., Schlautman J.D., Ciborowski P.S., Thomas M.P., and Gendelman H.E. Genomic and Proteomic Microglial Profiling: Pathways for Neuroprotective Inflammatory Responses Following Nerve Fragment Clearance and Activation. J. Neurochem. 102 (2007) 627-645
16. Greiner A., Lautwein A., Overkleeft H.S., Weber E., and Driessen C. Activity and subcellular distribution of cathepsins in primary human monocytes. J. Leukoc. Biol. 73 (2003) 235-242
17. Hartwig J.H., and Yin H.L. The organization and regulation of the macrophage actin skeleton. Cell Motil. Cytoskelet. 10 (1988) 117-125
18. Huhmer A.F., Biringer R.G., Amato H., Fonteh A.N., and Harrington M.G. Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges. Dis. Markers 22 (2006) 3-26
19. Irani D.N., Anderson C., Gundry R., Cotter R., Moore S., Kerr D., McArthur J.C., Sacktor N., Pardo C.A., Jones M., Calabresi P., and Nath A. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 59 (2006) 237-247
20. Kadiu I., Glanzer J.G., Kipnis J., Gendelman H.E., and Thomas M.P. Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases. Neurotox. Res. 8 (2005) 25-50
21. Kaul M., and Lipton A. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4 (2006) 307-318
22. Luo X., Carlson K.A., Wojna V., Mayo R., Biskup T.M., Stoner J., Anderson J., Gendelman H.E., and Melendez L.M. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 60 (2003) 1931-1937
23. MacGowan D.J., Scelsa S.N., and Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 57 (2001) 1094-1097
24. Mannes A.J., Martin B.M., Yang H.Y., Keller J.M., Lewin S., Gaiser R.R., and Iadarola M.J. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain 102 (2003) 251-256
25. McArthur J.C. Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirology 9 (2004) 205-221
26. Meléndez, L.M., Luciano, C. Mayo-Santana R., Wojna, V. In press. Ethnicity and neuro-AIDS conditions in the HAART Era. In: Goodkin, K., Shapshak, P., Verma, A. (Eds.), The Spectrum of NeuroAIDS Disorders: Pathophysiology, Diagnosis, and Treatment, ASM Press, Washington DC.
27. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., and Perno C.F. Oxidative stress and neuroAIDS: triggers, modulators, and novel antioxidants. TRENDS Neurosci. 24 (2001) 411-416
28. Moulignier A., Moulonguet A., Pialoux G., and Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology 57 (2001) 995-1001
29. Navia B.A., and Rostasy K. The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies. Neurotox. Res. 8 (2005) 3-24
30. Nishihira J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J. Interferon Cytokine Res. 20 (2000) 751-762
31. Omenn G.S., States D.J., Adamski M., Blackwell T.W., Menon R., Hermjakob H., Apweiler R., Haab B.B., Simpson R.J., Eddes J.S., Kapp E.A., Moritz R.L., Chan D.W., Rai A.J., Admon A., Aebersold R., Eng J., Hancock W.S., Hefta S.A., Meyer H., Paik Y.K., Yoo J.S., Ping P., Pounds J., Adkins J., Qian X., Wang R., Wasinger V., Wu C.Y., Zhao X., Zeng R., Archakov A., Tsugita A., Beer I., Pandey A., Pisano M., Andrews P., Tammen H., Speicher D.W., and Hanash S.M. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 (2005) 3226-3245
32. Pasinetti G.M., Ungar L.H., Lange D.J., Yemul S., Deng H., Yuan X., Brown R.H., Phil D., Cudkowicz M.E., Newhall K., Peskind E., Marcus S., and Ho L. Identification of potential CSF biomarkers in ALS. Neurology 66 (2006) 1218-1222
33. Pocernish C.B., Sultana R., Hone E., Turchan J., Martin R.N., Calabrese V., Nath A., and Butterfield D.A. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes. J. Neurosci. Res. 77 (2004) 532-539
34. Ranganathan S., Williams E., Ganchey P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown Jr. R.H., and Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 95 (2005) 1461-1471
35. Rozek, W., Ricardo-Dukelow, M., Holloway, S., Wojna, V., Gendelman, H.E., Melendez, L.M., Ciborowski, P., in press. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with or at risk for cognitive impairments. J. Proteome Res.
36. Rüetschi U., Zetterberg H., Podust V.N., Gottfries J., Li S., Simonsen A.H., McGuire J.M., Karlsson M., Rymo L., Davies H., Minthon L., and Blennow K. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp. Neurol. 196 (2005) 273-281
37. St. Hillaire C., Vargas D., Pardo C.A., Gincel D., Mann J., Rothstein J.D., McArthur J.C., and Conant K. Aquaporin 4 is increased in association with human immunodeficiency virus dementia: implications for disease pathogenesis. J. Neurovirology 11 (2005) 535-543
38. Storey J.D., Taylor J.E., and Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rates: a unified approach. J. R. Stat. Soc., Ser. B 66 (2004) 187-205
39. Treitinger A., Spada C., Verdi J.C., Miranda A.F., Oliveira O.V., Silveira M.V., Moriel P., and Abadía D.S. Decreased antioxidant defense in individuals infected by the human immunodeficiency virus. Eur. J. Clin. Investig. 30 (2000) 454-459
40. Vehmas A., Lieu J., Pardo C.A., McArthur J., and Gartner S. Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment. J. Neuroimmunol. 157 (2004) 99-110
41. Verma A., and Berger J.R. ALS syndrome in patients with HIV-1 infection. J. Neurol. Sci. 240 (2006) 59-64
42. Von Giesen H.J., Kaiser R., Koller H., Wetzel K., and Arendt G. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 59 (2006) 474-475
43. Wojna V., and Nath A. Challenges to the diagnosis and management of HIV dementia. AIDS Read. 16 (2006) 615-632
44. Wojna V., Gerena V., Ginebra T., Skolasky R., García H., Gendelman H.E., Kraiselburd E., McArthur J., Nath A., Zorrilla C., and Melendez L. Prevalence of HIV dementia in a group of Hispanic women at risk. J. Neurovirology 10 (2004) 88-89
45. Wojna V., Carlson K.A., Luo X., Mayo R., Melendez L.M., Kraiselburd E., and Gendelman H.E. Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study. J. Neurovirology 10 (2004) 74-81
46. Wojna V., Skolasky R., Hechavarria R., Mayo R., Selnes O., McArthur J., Melendez L., Maldonado E., Zorrilla C., Garcia H., Kraiselburd E., and Nath A. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J. Neurovirology 12 (2006) 356-364
47. Woods S.P., Carey C.L., Moran L.M., Dawson M.S., Letendre S.L., Grant I., and The HIV Neurobehavioral Research Center (HNRC) Group. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Arch. Clin. Neuropsychol. 22 (2007) 187-195
48. Yasui Y., McLerran D., Adam B.L., Winget M., Thornquist M., and Feng Z. An automated peak identification/calibration procedure for high-dimensional protein measures from mass spectrometers. J. Biomed. Biotechnol. (2003) 242-248
49. Yuan X., and Desiderio D.M. Proteomics analysis of human cerebrospinal fluid. J. Chromatogr. 815 (2005) 179-189